Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.38 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.38 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.34 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.34 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.34 |
| ▸ | PGR | P06401 | 1/20 | 0.34 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.34 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.34 |
| ▸ | HTR1A | P08908 | 1/20 | 0.34 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.34 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.34 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.34 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.34 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.34 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14926390 | 0.98 | ALDH1A1 (0.42) | ALDH1A1LMNAAPOBEC3AAPOBEC3GCHRM5 | |
| SCHEMBL14926379 | 0.93 | ALDH1A1 (0.41) | ALDH1A1LMNACHRM5CHRM1CHRM3 | |
| SCHEMBL13401900 | 0.86 | NAAA (0.48) | ALDH1A1SMN1; SMN2TSHRGAAEPHX2 | |
| SCHEMBL14926354 | 0.86 | POLB (0.40) | ALDH1A1SMN1; SMN2EPHX2MAPTNAAA | |
| SCHEMBL21524601 | 0.86 | ALDH1A1 (0.44) | ALDH1A1LMNAAPOBEC3AAPOBEC3GCHRM5 | |
| SCHEMBL6402662 | 0.85 | MAPT (0.38) | ALDH1A1MAPTPOLBPPM1BPTPN1 | |
| SCHEMBL24992573 | 0.84 | NAAA (0.52) | ALDH1A1TSHRRAB9AEPHX2MAPT | |
| SCHEMBL14926357 | 0.84 | ALDH1A1 (0.40) | ALDH1A1SMN1; SMN2EPHX2NAAAPOLB | |
| SCHEMBL15691940 | 0.84 | ALDH1A1 (0.45) | ALDH1A1TSHREPHX2NAAAPPM1B | |
| SCHEMBL18432927 | 0.83 | TSHR (0.51) | ALDH1A1TSHREPHX2MAPTPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10738242-B2 | Compound, cured product, polymer, photo-alignment film, optically anisotropic body and liquid crystal display element | DIC CORPORATION (JP) | 2020-08-11 | — | — | US | disclosed |
| US-9939555-B2 | Cinnamic acid derivative, polymer thereof, and liquid crystal alignment layer comprising cured product thereof | DIC CORPORATION (JP) | 2018-04-10 | — | — | US | disclosed |
| US-9939555-B2 | Cinnamic acid derivative, polymer thereof, and liquid crystal alignment layer comprising cured product thereof | DIC CORPORATION (JP) | 2018-04-10 | — | — | US | disclosed |
| US-9708535-B2 | Liquid crystal alignment layer | DIC CORPORATION (JP) | 2017-07-18 | — | — | US | disclosed |
| US-9708535-B2 | Liquid crystal alignment layer | DIC CORPORATION (JP) | 2017-07-18 | — | — | US | disclosed |
| US-9684206-B2 | Copolymer, and liquid crystal alignment layer including cured product thereof | DIC CORPORATION (JP) | 2017-06-20 | — | — | US | disclosed |
| US-9684206-B2 | Copolymer, and liquid crystal alignment layer including cured product thereof | DIC CORPORATION (JP) | 2017-06-20 | — | — | US | disclosed |
| US-20170088777-A1 | LIQUID CRYSTAL ALIGNMENT LAYER | DIC CORPORATION (JP) | 2017-03-30 | — | — | US | disclosed |
| US-20170088777-A1 | LIQUID CRYSTAL ALIGNMENT LAYER | DIC CORPORATION (JP) | 2017-03-30 | — | — | US | disclosed |
| US-20160274418-A1 | CINNAMIC ACID DERIVATIVE, POLYMER THEREOF, AND LIQUID CRYSTAL ALIGNMENT LAYER COMPRISING CURED PRODUCT THEREOF | DIC CORPORATION (JP) | 2016-09-22 | — | — | US | disclosed |
| US-9340634-B2 | Polymer for use in liquid crystal alignment layer | DIC CORPORATION (JP) | 2016-05-17 | — | — | US | disclosed |
| US-20140221574-A1 | COPOLYMER, AND LIQUID CRYSTAL ALIGNMENT LAYER INCLUDING CURED PRODUCT THEREOF | DIC CORPORATION (JP) | 2014-08-07 | — | — | US | disclosed |
| US-20140221574-A1 | COPOLYMER, AND LIQUID CRYSTAL ALIGNMENT LAYER INCLUDING CURED PRODUCT THEREOF | DIC CORPORATION (JP) | 2014-08-07 | — | — | US | disclosed |
| US-20140154428-A1 | CINNAMIC ACID DERIVATIVE, POLYMER THEREOF, AND LIQUID CRYSTAL ALIGNMENT LAYER COMPRISING CURED PRODUCT THEREOF | DIC CORPORATION (JP) | 2014-06-05 | — | — | US | disclosed |
| US-20140154428-A1 | CINNAMIC ACID DERIVATIVE, POLYMER THEREOF, AND LIQUID CRYSTAL ALIGNMENT LAYER COMPRISING CURED PRODUCT THEREOF | DIC CORPORATION (JP) | 2014-06-05 | — | — | US | disclosed |
| EP-2727903-A1 | CINNAMIC ACID DERIVATIVE, POLYMER THEREOF, AND LIQUID CRYSTAL ALIGNMENT LAYER COMPRISING HARDENED PRODUCT OF SAID POLYMER | DIC Corporation (JP) | 2014-05-07 | — | — | EP | disclosed |
| US-20140121345-A1 | CINNAMIC ACID DERIVATIVE, POLYMER THEREOF, AND LIQUID CRYSTAL ALIGNMENT LAYER COMPRISING CURED PRODUCT THEREOF | DIC CORPORATION (JP) | 2014-05-01 | — | — | US | disclosed |
| US-20140121345-A1 | CINNAMIC ACID DERIVATIVE, POLYMER THEREOF, AND LIQUID CRYSTAL ALIGNMENT LAYER COMPRISING CURED PRODUCT THEREOF | DIC CORPORATION (JP) | 2014-05-01 | — | — | US | disclosed |
| US-20130116396-A1 | POLYMER FOR USE IN LIQUID CRYSTAL ALIGNMENT LAYER | DIC CORPORATION (JP) | 2013-05-09 | — | — | US | disclosed |
| US-20130116396-A1 | POLYMER FOR USE IN LIQUID CRYSTAL ALIGNMENT LAYER | DIC CORPORATION (JP) | 2013-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10738242-B2 | Compound, cured product, polymer, photo-alignment film, optically anisotropic body and liquid crystal display element | PYM1, ZYX, CRY1 | ALDH1A1 2197/4885LMNA 1398/4885APOBEC3A 3373/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.